Latest filing published 19 Dec 2016 for Valeant Pharmaceuticals International, Inc., €53k.
Thomas Ross Sr. is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. We count 3 filings; the first trade dates from 8 March 2016 and the latest from 14 December 2016.
On the market, this insider has only ever bought: 2 purchases, €120k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 19 December 2016 with an open-market purchase (€53k) in Valeant Pharmaceuticals International, Inc. Filings reach the SEDI feed a median of 38 days after the trade. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations